Â鶹AV

In 1984 Dr. Basilion completed his BA in biochemistry at the University of Pennsylvania and entered the doctoral program at the Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston.  Following a post-doctoral fellowship at the National Institutes of Health (NICHD) and a short career in a Biotech startup, Dr. Basilion joined the Faculty of Harvard Medical School and MGH-Center for Molecular Imaging Research. In September 2005 Dr. Basilion joined the faculties of Medicine and Engineering at Case Western Reserve University. There he rose through the ranks and now is a full tenured professor in the Departments of Radiology and Biomedical Engineering and is currently Co-director of the Cancer Imaging Program for the Case Comprehensive Cancer Center. Previously he was the Vice-Chair for Basic Research at the Department of Radiology and the Director of the Case Center for Imaging Research. His research is translational in nature and he has founded two companies devoted to development of fluorescence image guided surgery for cancers. He has over 100 publications and over 50 issued/pending patents.

Angela Casini is Liesel Beckmann Distinguished Professor and Chair of Medicinal and Bioinorganic Chemistry, as well as ad interim Chair of Pharmaceutical Radiochemistry, at the Technical University of Munich (TUM, Germany). Angela completed her PhD in Chemistry at the University of Florence (Italy) in 2004, and, afterwards, moved to EPFL (Switzerland) as principal investigator funded by the Swiss National Science Foundation. Between 2011-2019, she was assistant professor at the University of Groningen (The Netherlands) and Chair at Cardiff University (UK). She is recipient of many awards and has authored more than 280 publications with a H-index of 77. Since 2023, she is member of the European Academy of Sciences.

Jason Davis is a Professor of Chemistry at Oxford & Senior Tutor in Chemistry at Christ Church. His group have published almost 200 research papers (averaging almost 50 citations per paper) in leading journals. His research interests are broad and primarily focussed on the design and utilisation of functional Interfaces, particularly those associated with molecular recognition and switching. This has included the design and generation of a broad range of responsive nanoparticulate systems, tools whereby supramolecular ion binding can be tracked by capacitance, modulated by local redox switches, surface polarisations or local dielectric. His team have invented new ways of transducing (macro)molecular recognition; open circuit potential methods, shotgun methods, rapid kinetic quantification, magnetic field promoted target capture, and the use of antigen mimick nanoparticles to capture cancer antibodies. Davis is the founder of Osler Diagnostics, a company that has now raised more than £150 million and employs close to 150 people. He was born in London, and lives in rural Oxfordshire with his wife, daughter and direwolves.

Gilles Gasser started his independent scientific career at the University of Zurich (Switzerland) in 2010 before moving to Chimie ParisTech, PSL University in 2016 to take a PSL Chair of Excellence. Gilles was the recipient of several fellowships and awards including the Alfred Werner Award from the Swiss Chemical Society, an ERC Consolidator Grant and Proof of Concept, the European BioInorganic Chemistry (EuroBIC), the Pierre Fabre Award for therapeutic innovation from the French Société de Chimie Thérapeutique, the Coordination Chemistry Prize from the French Chemical Society (Senior Level) and recently the Seqens Prize from the French Academy of Sciences for outstanding work in medicinal chemistry. Gilles’ research interests lay in the use of metal complexes in different areas of medicinal and biological chemistry.

Maryellen Giger, Ph.D. is the A.N. Pritzker Distinguished Service Professor of Radiology, Committee on Medical Physics, and the College at the University of Chicago.  Her AI research in cancer, neuro-imaging, COVID-19, and other diseases for risk assessment, diagnosis, prognosis, and therapeutic response has yielded various translated components, including “virtual biopsies”. She is contact PI for the Medical Imaging and Data Resource Center (MIDRC; midrc.org).  Giger has more than 290 peer-reviewed publications; more than 30 patents, and has mentored over 200 trainees. Giger is former president of AAPM and of SPIE; member of the National Academy of Engineering, recipient of the AAPM Gold Medal, SPIE Barrett Award in Medical Imaging, RSNA’s Outstanding Researcher Award, and Fellow of AAPM, AIMBE, SPIE, and IEEE. 

Duncan Graham is a Distinguished Professor, Associate Principal and Executive Dean of the Faculty of Science at the University of Strathclyde in Glasgow. He was appointed as a lecturer in 2002 at the University of Strathclyde and promoted to professor in 2004.
In 2007 he was elected to the Fellowship of the Royal Society of Edinburgh then awarded the Â鶹AV’s Corday Morgan prize in 2009, a Royal Society Wolfson Merit Award in 2010, the Craver Award of the Coblentz Society, a Fellows Award from the Society of Applied Spectroscopy in 2012, the Â鶹AV’s Theophilus Redwood award in 2016 and the FACSS Charles Mann Award in 2017.
Duncan served as Editor in Chief of the Â鶹AV journal Analyst for 7 years. He was president of the analytical division of the Â鶹AV (2017-2020), chair of the analytical chemistry trust fund (2017-2020) and then chaired the Publishing board of the Â鶹AV as well as serving as a trustee (2020-2024).  He has published over 300 papers with 17 patents and has supervised over 70 PhD students and 40 postdoctoral researchers.  His scientific interests are in developing new diagnostic assays based on nanoparticles and spectroscopy with target molecules including DNA, RNA, proteins and small molecule biomarkers

Tony D James is a Professor at the University of Bath and Fellow of the Â鶹AV. He has developed a broad interdisciplinary approach to research, with an underpinning focus on the development of modular sensors, where he has pioneered a range of reporting regimes. His research interests include many aspects of supramolecular chemistry, including molecular recognition, fluorescent sensor design, fluorescence imaging, chiral recognition, saccharide recognition, anion recognition, probes for redox imbalance and theranostic systems. He received his BSc from the University of East Anglia (1986), PhD from the University of Victoria (1991), and was a Postdoctoral Research Fellow in Japan with Seiji Shinkai (1992-95). He was awarded a Royal Society University Research Fellowship at the University of Birmingham (1995-2000) before moving to the University of Bath in 2000. He was a Royal Society Wolfson Research Merit Award holder from 2017 to 2022. He has published over 500 publications in international peer reviewed journals, h-index of 96 and is listed by Clarivate as a Highly Cited Researcher since 2022.

Xingyu Jiang is a Chair Professor at the Southern University of Science and Technology, Shenzhen, China. He obtained his B.S. at the University of Chicago in 1999 and his Ph.D. at Harvard University in 2004. He started a lab at the National Center of NanoScience&Technology of China in 2005. In 2018, he moved to the current position. His research in microfluidics has been recognized by many awards including National Distinguished Young Scholars Award, and the Tencent Exploration Award. He is a Fellow of the Chinese Chemical Society and the Â鶹AV.

Kazuya Kikuchi FÂ鶹AV obtained his Ph.D. from the university of Tokyo in 1994, then, a postdoctoral fellow with Prof. Roger Y. Tsien UCSD. Subsequently, he moved to Prof. Donald Hilvert laboratory at the Scripps research Institute. He returned Japan as a research associate at the university of Tokyo in 1997, and promoted to an associate professor in 2000. He moved to Osaka University as a professor in 2005, currently a distinguished professor. During this period he became involved in molecular imaging probes development for both fluorescence and magnetic resonance imaging. He is focused both in in vivo imaging and single molecule cellular imaging.

Nick Long holds the Sir Edward Frankland BP Endowed Chair in Inorganic Chemistry at Imperial College London.  He is a leader in applied synthetic inorganic and organometallic chemistry, with research interests focussing on transition metal and lanthanide chemistry for the synthesis of functional electronic and renewable energy materials, homogeneous catalysts and probes for biomedical imaging.  He has around 270 publications, with over 16000 citations, an h-index of 60, and i10-index of 185.  His work has recently been recognised by a Royal Society Wolfson Merit Award (2018), the Â鶹AV Frankland Award (2020), and the Â鶹AV Interdisciplinary Prize (2023). Nick is a co-Founder of the King’s/Imperial EPSRC CDT in Medical Imaging and has been its Deputy Director since 2013. He is a Fellow of the European Academy of Sciences (FEurASc) and served on the UK REF2021 Chemistry panel.

Dr Michelle Ma completed her PhD at the University of Melbourne, with Prof Paul Donnelly. In 2012 she moved from Australia to London, to take up a Newton International Fellowship and a Marie Curie Fellowship at King's College London, where she is still based. Michelle is currently a Cancer Research UK Career Establishment Fellow. Her research develops and applies inorganic chemistry to understand and image molecular processes in cancer, with a particular focus on radiopharmaceuticals. Michelle also enjoys a good chat, swimming, terrible 90s music, being out in the sunshine or alternately, sitting in the dark at the back of a cinema.